- Home
- TRGP vs HLN Comparison
TRGP vs HLN Comparison
Compare TRGP & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRGP
- HLN
- Stock Information
- Founded
- TRGP 2005
- HLN 2022
- Country
- TRGP United States
- HLN United Kingdom
- Employees
- TRGP N/A
- HLN N/A
- Industry
- TRGP Natural Gas Distribution
- HLN Package Goods/Cosmetics
- Sector
- TRGP Utilities
- HLN Consumer Discretionary
- Exchange
- TRGP Nasdaq
- HLN Nasdaq
- Market Cap
- TRGP 44.8B
- HLN 43.3B
- IPO Year
- TRGP 2010
- HLN N/A
- Fundamental
- Price
- TRGP $200.37
- HLN $10.08
- Analyst Decision
- TRGP Strong Buy
- HLN Strong Buy
- Analyst Count
- TRGP 15
- HLN 2
- Target Price
- TRGP $197.67
- HLN $10.48
- AVG Volume (30 Days)
- TRGP 1.4M
- HLN 9.3M
- Earning Date
- TRGP 02-20-2025
- HLN 03-07-2025
- Dividend Yield
- TRGP 1.50%
- HLN 1.57%
- EPS Growth
- TRGP 60.07
- HLN N/A
- EPS
- TRGP 5.86
- HLN 0.18
- Revenue
- TRGP $16,381,500,000.00
- HLN $15,065,004,686.00
- Revenue This Year
- TRGP $11.98
- HLN $2.44
- Revenue Next Year
- TRGP $25.08
- HLN $2.88
- P/E Ratio
- TRGP $34.22
- HLN $27.27
- Revenue Growth
- TRGP 2.00
- HLN N/A
- 52 Week Low
- TRGP $95.88
- HLN $7.89
- 52 Week High
- TRGP $218.51
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- TRGP 48.16
- HLN 65.11
- Support Level
- TRGP $195.42
- HLN $9.86
- Resistance Level
- TRGP $211.87
- HLN $10.06
- Average True Range (ATR)
- TRGP 5.87
- HLN 0.11
- MACD
- TRGP -0.51
- HLN 0.04
- Stochastic Oscillator
- TRGP 31.51
- HLN 97.97
About TRGP Targa Resources Inc.
Targa Resources is a midstream firm that primarily operates gathering and processing assets with substantial positions in the Permian, Stack, Scoop, and Bakken plays. It has fractionation capacity at Mont Belvieu and operates a liquefied petroleum gas export terminal. The Grand Prix natural gas liquids pipeline is another important asset.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.